Overview
- The EPA, in a draft Sixth Contaminant Candidate List released Thursday, added microplastics and pharmaceuticals for the first time and opened a 60-day public comment period, with finalization expected by mid-November.
- HHS launched STOMP, a roughly $144 million ARPA-H program to measure microplastics in people, study health effects, and build practical tools such as a fast, low-cost clinical test.
- EPA officials stressed that placement on the list does not regulate the substances, and the agency plans to publish human-health benchmarks for about 374 pharmaceuticals to guide monitoring and risk evaluation.
- Scientists and industry groups warned that key hurdles remain, including a lack of standardized detection methods for micro- and nanoplastics and limited lab capacity, while advocacy groups called the move a useful first step and urged faster action.
- The announcement aligns with the Make America Healthy Again agenda and drew mixed coverage, with some outlets highlighting an aggressive push on microplastics and others noting that past EPA watchlists rarely led to binding drinking-water standards.